Avitas Wealth Management LLC lifted its holdings in Exponent, Inc. (NASDAQ:EXPO) by 35.8% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 14,898 shares of the business services provider’s stock after buying an additional 3,924 shares during the period. Avitas Wealth Management LLC’s holdings in Exponent were worth $1,041,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of the company. Tower Research Capital LLC TRC grew its holdings in Exponent by 787.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 612 shares of the business services provider’s stock valued at $36,000 after purchasing an additional 543 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in Exponent by 98.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 1,410 shares of the business services provider’s stock valued at $99,000 after purchasing an additional 700 shares during the last quarter. NN Investment Partners Holdings N.V. bought a new position in Exponent during the 2nd quarter valued at about $91,000. Park Avenue Securities LLC bought a new position in Exponent during the 3rd quarter valued at about $224,000. Finally, Cim LLC bought a new position in Exponent during the 2nd quarter valued at about $200,000. Hedge funds and other institutional investors own 88.18% of the company’s stock.
Exponent stock opened at $65.63 on Monday. The stock has a market cap of $3.68 billion, a price-to-earnings ratio of 52.50 and a beta of 0.41. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.60 and a quick ratio of 3.60. Exponent, Inc. has a 1 year low of $44.44 and a 1 year high of $72.70. The firm has a 50-day moving average of $70.12 and a two-hundred day moving average of $62.92.
Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, October 17th. The business services provider reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.02. Exponent had a net margin of 19.88% and a return on equity of 24.13%. The company had revenue of $101.50 million during the quarter, compared to analysts’ expectations of $100.17 million. During the same period in the previous year, the company earned $0.32 EPS. The firm’s quarterly revenue was up 6.5% on a year-over-year basis. Research analysts expect that Exponent, Inc. will post 1.49 earnings per share for the current year.
In related news, insider Harri Kytomaa sold 2,000 shares of the stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $70.09, for a total transaction of $140,180.00. Following the completion of the sale, the insider now owns 9,399 shares of the company’s stock, valued at $658,775.91. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John Pye sold 3,000 shares of the stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $70.31, for a total transaction of $210,930.00. Following the sale, the insider now directly owns 25,747 shares of the company’s stock, valued at approximately $1,810,271.57. The disclosure for this sale can be found here. Insiders sold a total of 102,773 shares of company stock valued at $7,227,536 in the last ninety days. Corporate insiders own 2.30% of the company’s stock.
Several equities analysts recently commented on EXPO shares. Cantor Fitzgerald upped their price target on shares of Exponent from $64.00 to $73.00 and gave the company an “overweight” rating in a report on Friday, July 19th. ValuEngine downgraded shares of Exponent from a “hold” rating to a “sell” rating in a report on Wednesday, October 2nd. BidaskClub downgraded shares of Exponent from a “buy” rating to a “hold” rating in a report on Thursday, September 26th. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “strong-buy” rating and set a $81.00 price target on the stock in a report on Monday, September 23rd. Finally, DA Davidson started coverage on shares of Exponent in a report on Wednesday, August 28th. They set a “neutral” rating on the stock. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $76.75.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.